Toxicology study of human complement factor H antibody GT103 in mice period of performance 12/19/2018 - 12/18/2019
Ended Awarded Last action
- Contract number
- 75N91019F00090
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $358,997
Award facts
- Opportunity
-
- N02CM4700142 Solicitation number
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Jul 6, 2016
- Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
- Contract value 100% obligated
- $358,997.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35255, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $358,997 |
About this award
The National Cancer Institute issued a delivery order to Southern Research Institute on December 18, 2018, under the Toxicology of Drugs Developed for Cancer Patients IDIQ, with a ceiling value of $358,997.
The order funds a toxicology study of human complement factor H antibody GT103 in mice. Place of performance is Birmingham, AL. Period of performance runs from December 19, 2018, through March 31, 2020. The contract is priced on a cost-plus-fixed-fee basis with no set-aside.
Southern Research self-performed the work; no subcontractors were reported. In fiscal year 2020, the order generated $154 thousand in invoiced labor, with all hours performed by the prime.
Quick answers
Who was awarded contract 75N91019F00090?
75N91019F00090 was awarded to Southern Research Institute by National Cancer Institute (National Institutes of Health) on December 18, 2018.
How much is contract 75N91019F00090 worth?
The government has obligated $358,997 on 75N91019F00090.
Is contract 75N91019F00090 an order under another contract?
Yes. 75N91019F00090 is a delivery order under HHSN261201600018I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.
Was contract 75N91019F00090 competed?
The extent of competition for 75N91019F00090 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award